Digital transformation in pharma is not just about technology, it’s about speeding up processes to deliver critical treatments. In this video, Fujifilm Diosynth Biotechnologies shares insights on reducing lead time, leveraging data, and engaging people to transform complex manufacturing and supply chains.

Digital transformation at scale
Fujifilm Diosynth Biotechnologies shares how they tackle digital transformation in a complex, highly regulated production environment. The video explores their vision to reduce lead times, integrate digital systems, and deliver medicines faster to patients. Key initiatives include one-click tech transfer, modular manufacturing, no-touch release, and end-to-end data access.

Impact on efficiency and people
The transformation improves efficiency by reducing manual tasks and paperwork while ensuring compliance. Equally important is the people aspect, with engagement across the shop floor and multidisciplinary teams. The approach emphasizes empathy, involvement, and clear communication to help staff adapt to new ways of working.

Long-term vision and lessons learned
Fujifilm Diosynth Biotechnologies focuses on tangible results and sustainable growth rather than relying solely on technology. They highlight the importance of building standards early, prioritizing business value, and embracing modular solutions. Digital transformation is presented as a long-term, evolving journey that balances technology, people, and purpose.